News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Related Stories News AdsDrama Launches Short-Drama Marketing Ecosystem Launch in the Dominican Republic, Paving the Way for Digital Content Innovation News Forbes Business Council Accepts Komodo Luxury Founder Agung Afif as Member News MD Pharma’s UVeCARE Celebrates Major Win at Natural Health Awards 2025 News 0G Ships Major Infrastructure Upgrade: Geth-to-Reth Validator Migration News TSplus Announces Remote Access v19.10: Enhanced Enterprise Security and Infrastructure Synchronization News SAGT Launches SAGE AI, Secures USD 11 Million in Enterprise Contracts to Drive AI-Powered Restaurant Transformation Across Southeast Asia
